{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:03:33Z","timestamp":1790870613428,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clnu.2026.106694","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:45:43Z","timestamp":1779428743000},"page":"106694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness of Taurolidine as secondary prevention of recurrent catheter-related bloodstream infections in patients with chronic intestinal failure: Findings from a randomized controlled trial"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0452-3739","authenticated-orcid":false,"given":"Camilla T.","family":"Nerstr\u00f8m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Scheike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus E.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri","family":"Tribler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle B.","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clnu.2026.106694_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3945\/ajcn.117.158964","article-title":"Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial","volume":"106","author":"Tribler","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnu.2026.106694_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/apt.14904","article-title":"Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition","volume":"48","author":"Wouters","year":"2018","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.clnu.2026.106694_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clnu.2025.05.020","article-title":"Taurolidine lock reduces recurrent catheter-related bloodstream infections in patients with chronic intestinal failure: a randomized, placebo-controlled trial in a real-world clinical setting","volume":"51","author":"Nerstr\u00f8m","year":"2025","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnu.2026.106694_bib4","first-page":"761","volume":"35","author":"Arnoriaga Rodr\u00edguez","year":"2018"},{"issue":"3","key":"10.1016\/j.clnu.2026.106694_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0148607114525804","article-title":"Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial","volume":"39","author":"Klek","year":"2015","journal-title":"JPEN - J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2026.106694_bib6","series-title":"Methods for the economic evaluation of health care programmes","first-page":"445","author":"Drummond","year":"2015"},{"key":"10.1016\/j.clnu.2026.106694_bib7","series-title":"Denmark: health system review","year":"2012"},{"key":"10.1016\/j.clnu.2026.106694_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.clnu.2026.106694_bib11","unstructured":"V\u00e6rdis\u00e6tning af enhedsomkostninger-vers. 1.2 [Internet]. Available from: https:\/\/medicinraadet.dk\/media\/gpjgcotu\/v%C3%A6rdis%C3%A6tning-af-enhedsomkostninger-vers-1-7.pdf."},{"key":"10.1016\/j.clnu.2026.106694_bib12","series-title":"DRG-takster","year":"2024"},{"key":"10.1016\/j.clnu.2026.106694_bib13","unstructured":"XE [Internet]. XE. [cited 2025 Jan 28]. Available from: https:\/\/www.xe.com."},{"issue":"8","key":"10.1016\/j.clnu.2026.106694_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<911::AID-SIM544>3.0.CO;2-I","article-title":"Marginal analysis of recurrent events and a terminating event","volume":"16","author":"Cook","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.clnu.2026.106694_bib15","series-title":"Nonparametric analysis of recurrent events and death","author":"Ghosh","year":"2000"},{"issue":"3","key":"10.1016\/j.clnu.2026.106694_bib16","first-page":"663","article-title":"Marginal regression models for recurrent and terminal events","volume":"12","author":"Ghosh","year":"2002","journal-title":"Stat Sin"},{"issue":"1","key":"10.1016\/j.clnu.2026.106694_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/biostatistics\/1.1.35","article-title":"Linear regression analysis of censored medical costs","volume":"1","author":"Lin","year":"2000","journal-title":"Biostatistics"},{"issue":"4","key":"10.1016\/j.clnu.2026.106694_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.0006-341X.2001.01002.x","article-title":"On estimating medical cost and incremental cost-effectiveness ratios with censored data","volume":"57","author":"Zhao","year":"2001","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.clnu.2026.106694_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/biomet\/87.2.329","article-title":"Estimating medical costs with censored data","volume":"87","author":"Bang","year":"2000","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.clnu.2026.106694_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.0006-341X.2000.00775.x","article-title":"Proportional means regression for censored medical costs","volume":"56","author":"Lin","year":"2000","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.clnu.2026.106694_bib21","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"issue":"4","key":"10.1016\/j.clnu.2026.106694_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clnu.2009.12.005","article-title":"Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial","volume":"29","author":"Bisseling","year":"2010","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2026.106694_bib23","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.clnu.2021.01.017","article-title":"Cost-effectiveness of taurolidine locks to prevent recurrent catheter-related blood stream infections in adult patients receiving home parenteral nutrition: a 2-year mirror-image study","volume":"40","author":"Lannoy","year":"2021","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2026.106694_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jpen.2589","article-title":"Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition","volume":"48","author":"Williams","year":"2024","journal-title":"J Parenter Enter Nutr"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:41:21Z","timestamp":1790869281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426001214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":22,"alternative-id":["S0261561426001214"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106694","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of Taurolidine as secondary prevention of recurrent catheter-related bloodstream infections in patients with chronic intestinal failure: Findings from a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106694"}}